[September 06, 2017]

Global Intrauterine Contraceptive Devices Market - Growth, Trends & Forecasts to 2022 - Research and Markets

The "Global Intrauterine Contraceptive Devices Market - Growth, Trends and Forecasts 2017 - 2022" report has been added to Research and Markets' offering.

The Global Intra Uterine contraceptive Devices market is estimated to be USD 1,370 million in 2016 and is expected to reach USD 2,267 million by 2021, growing at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2016 to 2021.

IUDs are small contraceptive devices, often T-shaped, containing either copper or levonorgestrel, which are inserted into the uterus. They are a form of long-acting contraception and are the most effective type of reversible birth control.

The report details several factors driving and restraining the global market for IUDs. The opportunities and challenges for the market are also discussed. Some of these are listed below:

Drivers

• Technological innovations
• Increase in the prevalence of Sexually Transmitted Diseases (STD)
• Pregnancy prevention
• Immediate health benefits other than birth control
• Rise in government initiatives o prevent unwanted abortions and pregnancies

• Cultural or religious oppositions prevalent in many countries
• Limited access to contraception
• Infertility issues
• Economic constraints
• Opportunities and Challenges

The new products that are in the research pipeline and the belief that IUDs are the safest contraceptives are some of the market opportunities for the key players. However, they also face the challenge of dealing with the threat of Pelvic Inflammatory Infection (PFD) and ectopic pregnancy as a result of the use of IUDs.

Companies Mentioned:

• Bayer Healthcare
• Pfizer
• Merck & Co.
• Teva Pharmaceuticals, Ltd.
• Agile (News - Alert) Therapeutics
• Actavis PLC
• ANI Pharmaceuticals, Inc.
• Church & Dwight, Co. Inc.
• Fuji Latex Co., Ltd
• Johnson & Johnson, Ltd
• Lupin Pharmaceuticals, Ltd
• Okamato Industries, Inc.
• Reckitt Benckiser Group, PLC
• The Female Health Company
• Mylan Laboratories

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry Trends

6. Drivers, Restraints, Opportunities and Challenges Analysis

7. Global Intra Uterine Device Segmentation

8. Global Intra Uterine Device Market by Geography - Regional shares and forecast

9. Competitive Landscape

10. Key Vendors

11. Analyst outlook for investment opportunities

12. Future outlook of the market

13. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/nwh55k/global

View source version on businesswire.com: http://www.businesswire.com/news/home/20170906005943/en/

[ Back To TMCnet.com's Homepage ]